Início › Câncer de Mama › Tennessee › Memphis
Ensaios clínicos de Câncer de Mama em Memphis, TN
22 estudos para Câncer de Mama estão buscando participantes em locais em Memphis e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RecrutandoFase 1/2
- The West Cancer Center, Memphis
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RecrutandoFase 1/2
- Baptist Cancer Center - Memphis, Memphis
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RecrutandoFase 3
- Baptist Memorial Healthcare, Memphis
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
RecrutandoFase 2
- West Cancer Center, Germantown · a 14 mi de distância
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutando
- West Cancer Center, Germantown · a 14 mi de distância
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RecrutandoFase 3
- Clinical Trial Site, Bartlett · a 11 mi de distância
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecrutandoFase 3
- The West Clinic, P.C. dba West Cancer Center, Germantown · a 14 mi de distância
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Baptist Cancer Center, Memphis
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RecrutandoFase 1/2
- The West Clinic, Germantown · a 14 mi de distância
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Recrutando
- The West Clinic, PC dba West Cancer Center, Germantown · a 14 mi de distância
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RecrutandoFase 3
- West Cancer Center, Germantown · a 14 mi de distância
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi de distância
- The West Clinic - Wolf River, Germantown · a 14 mi de distância
- e mais 1
E-Mindfulness Approaches for Living After Breast Cancer
RecrutandoFase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi de distância
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- The West Clinic, PLLC dba West Cancer Center, Germantown · a 14 mi de distância
Familial Investigations of Childhood Cancer Predisposition
RecrutandoEstudo observacional
- St. Jude Children's Research Hospital, Memphis
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecrutandoFase 3
- The West Clinic, PLLC dba West Cancer Center, Germantown · a 14 mi de distância
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital for Women, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · a 11 mi de distância
- e mais 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Memphis
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecrutandoFase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #11, Germantown · a 14 mi de distância
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RecrutandoEstudo observacional
- West Cancer Center, Germantown · a 14 mi de distância
Ensaios de Câncer de Mama em outras cidades
- New York City, NY136 estudos
- Houston, TX126 estudos
- Boston, MA112 estudos
- Nashville, TN81 estudos
- Los Angeles, CA73 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Queens, NY64 estudos
- Durham, NC64 estudos
- Chicago, IL59 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Memphis
- Câncer (todos os tipos)31 estudos
- Câncer de Pulmão de Não Pequenas Células23 estudos
- Câncer de Pulmão18 estudos
- Doença Falciforme18 estudos
- Leucemia Linfoblástica Aguda16 estudos
- Leucemia Mieloide Aguda15 estudos
- Insuficiência Cardíaca13 estudos
- Sarcoma de Tecido Mole11 estudos
- Melanoma11 estudos
- Câncer de Próstata11 estudos
- Câncer Colorretal11 estudos
- Osteossarcoma10 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.